| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
24,093 |
21,826 |
$2.06M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,364 |
9,729 |
$929K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
7,665 |
7,219 |
$580K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
6,732 |
6,617 |
$573K |
| 92551 |
|
12,064 |
10,373 |
$538K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,024 |
5,808 |
$523K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
5,557 |
5,450 |
$420K |
| 99173 |
|
10,654 |
9,386 |
$273K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,897 |
2,673 |
$247K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
3,250 |
3,182 |
$234K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,659 |
1,461 |
$186K |
| 99442 |
|
2,008 |
1,870 |
$125K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
19,419 |
14,123 |
$108K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,528 |
1,491 |
$108K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
1,191 |
1,151 |
$99K |
| 99441 |
|
2,233 |
2,142 |
$97K |
| 90686 |
|
7,164 |
7,144 |
$94K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
7,490 |
7,372 |
$69K |
| 1126F |
|
24,662 |
20,752 |
$59K |
| 83655 |
|
4,221 |
4,203 |
$52K |
| 97802 |
|
1,231 |
1,154 |
$49K |
| 99443 |
|
744 |
715 |
$46K |
| 36415 |
Collection of venous blood by venipuncture |
18,453 |
16,915 |
$42K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
6,194 |
6,091 |
$42K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
8,345 |
8,304 |
$34K |
| 82652 |
|
2,494 |
2,483 |
$33K |
| 96127 |
|
11,775 |
10,944 |
$30K |
| 80053 |
Comprehensive metabolic panel |
7,643 |
7,586 |
$28K |
| 80061 |
Lipid panel |
10,827 |
10,783 |
$28K |
| 97803 |
|
752 |
716 |
$26K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,027 |
3,010 |
$25K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
10,027 |
9,962 |
$23K |
| 1159F |
|
29,809 |
26,068 |
$21K |
| 90651 |
|
1,743 |
1,741 |
$21K |
| 84443 |
Thyroid stimulating hormone (TSH) |
8,194 |
8,115 |
$19K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
17,667 |
17,547 |
$19K |
| 99215 |
Prolong outpt/office vis |
171 |
169 |
$16K |
| 84439 |
|
6,930 |
6,875 |
$15K |
| 86803 |
|
5,991 |
5,963 |
$14K |
| 90671 |
|
369 |
368 |
$13K |
| 81001 |
|
12,955 |
8,624 |
$13K |
| 96161 |
|
983 |
946 |
$11K |
| 90620 |
|
1,307 |
1,303 |
$11K |
| 90670 |
|
1,819 |
1,813 |
$11K |
| 86480 |
|
443 |
442 |
$10K |
| 90461 |
|
1,773 |
1,757 |
$10K |
| 90715 |
|
1,057 |
1,057 |
$9K |
| 90633 |
|
1,568 |
1,559 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,299 |
2,252 |
$9K |
| 90698 |
|
1,343 |
1,337 |
$8K |
| 83525 |
|
2,250 |
2,231 |
$6K |
| 90734 |
|
1,401 |
1,397 |
$6K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,955 |
1,943 |
$6K |
| 90710 |
|
490 |
488 |
$5K |
| 90680 |
|
836 |
833 |
$5K |
| 82728 |
|
1,097 |
1,091 |
$4K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
294 |
264 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
381 |
372 |
$4K |
| 86706 |
|
1,596 |
1,591 |
$4K |
| 86592 |
|
4,154 |
4,119 |
$4K |
| 90660 |
|
626 |
625 |
$4K |
| 86780 |
|
1,593 |
1,559 |
$4K |
| 87340 |
|
1,651 |
1,629 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
207 |
207 |
$3K |
| 90672 |
|
225 |
225 |
$3K |
| 90723 |
|
507 |
506 |
$3K |
| 82607 |
|
790 |
789 |
$3K |
| 83021 |
|
408 |
397 |
$3K |
| 90744 |
|
928 |
928 |
$3K |
| 82746 |
|
632 |
631 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
21 |
21 |
$2K |
| 81003 |
|
3,158 |
3,145 |
$2K |
| 88142 |
|
399 |
395 |
$2K |
| 86580 |
|
2,156 |
2,056 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
255 |
254 |
$2K |
| 86762 |
|
661 |
649 |
$2K |
| 90685 |
|
160 |
160 |
$2K |
| 90696 |
|
529 |
529 |
$2K |
| 87088 |
|
1,124 |
1,088 |
$2K |
| 90750 |
|
52 |
52 |
$2K |
| 90619 |
|
92 |
92 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
14 |
14 |
$2K |
| 87070 |
|
1,524 |
1,508 |
$2K |
| 86765 |
|
588 |
583 |
$2K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
130 |
130 |
$2K |
| 83550 |
|
957 |
951 |
$2K |
| 90688 |
|
519 |
518 |
$2K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
69 |
69 |
$1K |
| 85660 |
|
728 |
726 |
$1K |
| 81025 |
|
3,432 |
2,178 |
$1K |
| 90716 |
|
208 |
207 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
12 |
12 |
$1K |
| 86593 |
|
1,512 |
1,496 |
$1K |
| 86787 |
|
735 |
728 |
$1K |
| 99385 |
|
12 |
12 |
$1K |
| 82043 |
|
854 |
844 |
$1K |
| 1160F |
|
29,216 |
26,073 |
$1K |
| S9470 |
Nutritional counseling, dietitian visit |
520 |
513 |
$1K |
| 86735 |
|
543 |
538 |
$1K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
130 |
130 |
$1K |
| 87338 |
|
204 |
202 |
$1K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
60 |
60 |
$1K |
| 86140 |
|
911 |
904 |
$993.96 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
432 |
421 |
$987.34 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
210 |
208 |
$963.38 |
| 90707 |
|
115 |
115 |
$932.14 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
12 |
12 |
$880.42 |
| 82962 |
|
2,531 |
2,265 |
$828.18 |
| 99406 |
|
39 |
32 |
$791.18 |
| 82947 |
|
724 |
699 |
$743.77 |
| 83020 |
|
284 |
284 |
$735.23 |
| 84702 |
|
213 |
212 |
$585.29 |
| 86696 |
|
133 |
132 |
$560.83 |
| 86704 |
|
251 |
250 |
$555.32 |
| 96160 |
|
38 |
34 |
$533.83 |
| 85610 |
|
115 |
110 |
$415.64 |
| 82570 |
|
293 |
280 |
$363.02 |
| 86695 |
|
124 |
123 |
$361.66 |
| 85730 |
|
104 |
100 |
$302.41 |
| 90647 |
|
72 |
72 |
$249.90 |
| 90681 |
|
20 |
20 |
$204.67 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
136 |
135 |
$196.33 |
| 80305 |
|
68 |
68 |
$172.63 |
| 84481 |
|
43 |
43 |
$169.94 |
| 84156 |
|
179 |
174 |
$168.70 |
| 84153 |
|
31 |
31 |
$147.12 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
12 |
12 |
$125.94 |
| 80076 |
|
27 |
27 |
$117.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
112 |
98 |
$112.87 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
351 |
343 |
$108.16 |
| 90662 |
|
12 |
12 |
$107.60 |
| 84999 |
|
447 |
442 |
$87.51 |
| 84210 |
|
14 |
14 |
$81.99 |
| 87210 |
|
186 |
186 |
$77.16 |
| 86003 |
|
12 |
12 |
$54.75 |
| 86703 |
|
32 |
32 |
$45.51 |
| 83540 |
|
25 |
25 |
$45.27 |
| 86038 |
|
26 |
26 |
$36.32 |
| 90648 |
|
23 |
23 |
$35.70 |
| 94760 |
|
323 |
323 |
$33.28 |
| 87400 |
|
354 |
350 |
$29.36 |
| 82270 |
|
53 |
28 |
$24.32 |
| 85046 |
|
29 |
29 |
$10.01 |
| 85008 |
|
38 |
38 |
$8.67 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
13 |
13 |
$4.17 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
48 |
46 |
$0.12 |
| 3051F |
|
37 |
31 |
$0.01 |
| 1031F |
|
637 |
624 |
$0.00 |
| 1125F |
|
2,731 |
2,540 |
$0.00 |
| 3008F |
|
23,377 |
21,279 |
$0.00 |
| 3044F |
|
5,671 |
5,160 |
$0.00 |
| 4293F |
|
1,136 |
1,133 |
$0.00 |
| 3049F |
|
804 |
716 |
$0.00 |
| 3079F |
|
2,166 |
2,049 |
$0.00 |
| 3074F |
|
6,686 |
6,077 |
$0.00 |
| 1036F |
|
4,596 |
4,138 |
$0.00 |
| 3061F |
|
842 |
748 |
$0.00 |
| 3080F |
|
557 |
525 |
$0.00 |
| 3075F |
|
1,301 |
1,244 |
$0.00 |
| 3048F |
|
1,706 |
1,518 |
$0.00 |
| 1111F |
|
331 |
275 |
$0.00 |
| 4010F |
|
332 |
288 |
$0.00 |
| 1170F |
|
644 |
535 |
$0.00 |
| 4000F |
|
22 |
22 |
$0.00 |
| 1035F |
|
29 |
25 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
13 |
12 |
$0.00 |
| 3077F |
|
1,038 |
965 |
$0.00 |
| 3062F |
|
2,262 |
1,989 |
$0.00 |
| 3078F |
|
6,236 |
5,708 |
$0.00 |
| 3288F |
|
614 |
513 |
$0.00 |
| 3725F |
|
4,163 |
4,080 |
$0.00 |
| 1033F |
|
3,184 |
2,884 |
$0.00 |
| 3046F |
|
1,320 |
1,178 |
$0.00 |
| 3050F |
|
387 |
346 |
$0.00 |
| 3210F |
|
14 |
14 |
$0.00 |